DIM
ABBV icon

Delta Investment Management’s AbbVie ABBV Stock Holding History

Delta Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$997K Sell
3,963
-138
-3% -$29.7K 0.16% 110
2026
Q1 		$892K Buy
4,101
+89
+2% +$19.7K 0.16% 101
2025
Q4 		$917K Buy
4,012
+106
+3% +$24.1K 0.16% 106
2025
Q3 		$904K Sell
3,906
-3
-0.1% -$611 0.16% 95
2025
Q2 		$726K Sell
3,909
-132
-3% -$24.5K 0.14% 102
2025
Q1 		$847K Buy
4,041
+253
+7% +$49.2K 0.17% 77
2024
Q4 		$673K Buy
3,788
+2
+0.1% +$368 0.13% 99
2024
Q3 		$748K Sell
3,786
-2
-0.1% -$373 0.15% 86
2024
Q2 		$650K Buy
3,788
+154
+4% +$25.5K 0.14% 91
2024
Q1 		$662K Sell
3,634
-399
-10% -$68.8K 0.15% 101
2023
Q4 		$625K Buy
4,033
+30
+0.7% +$4.37K 0.16% 91
2023
Q3 		$597K Buy
4,003
+1
+0% +$147 0.17% 77
2023
Q2 		$539K Buy
4,002
+2
+0.1% +$293 0.15% 85
2023
Q1 		$638K Sell
4,000
-12
-0.3% -$1.83K 0.18% 75
2022
Q4 		$648K Buy
4,012
+14
+0.4% +$2.15K 0.21% 74
2022
Q3 		$537K Sell
3,998
-12
-0.3% -$1.72K 0.23% 78
2022
Q2 		$614K Sell
4,010
-164
-4% -$25.1K 0.28% 67
2022
Q1 		$677K Buy
4,174
+3
+0.1% +$436 0.2% 64
2021
Q4 		$565K Buy
4,171
+3
+0.1% +$354 0.16% 93
2021
Q3 		$450K Buy
4,168
+137
+3% +$15.7K 0.14% 108
2021
Q2 		$454K Hold
4,031
– – 0.13% 107
2021
Q1 		$436K Sell
4,031
-1,582
-28% -$169K 0.14% 105
2020
Q4 		$601K Sell
5,613
-16
-0.3% -$1.54K 0.19% 91
2020
Q3 		$493K Sell
5,629
-193
-3% -$18.2K 0.27% 59
2020
Q2 		$571K Buy
5,822
+526
+10% +$46.3K 0.24% 74
2020
Q1 		$403K Buy
5,296
+1,927
+57% +$164K 0.31% 45
2019
Q4 		$298K Buy
+3,369
New +$280K 0.11% 101

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Delta Investment Management's ABBV Position: Q2 2026 in Review

Delta Investment Management reduced its AbbVie (ABBV) stake by 3.4% in Q2 2026, selling an estimated $29.7K and leaving 3,963 shares worth $997K. The position accounts for 0.16% of the portfolio, ranked #110.

Delta Investment Management first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,232 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Delta Investment Management held 3,963 shares of AbbVie worth $997K as of Q2 2026.
  • Delta Investment Management sold 138 AbbVie shares in Q2 2026, an estimated $29.7K.
  • AbbVie made up 0.16% of Delta Investment Management's portfolio in Q2 2026, its #110 holding.
  • Delta Investment Management first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 4,232 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Delta Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.